Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ticagrelor Tablets

Approval Number

国药准字H20227019

Company扬子江药业集团广州海瑞药业有限公司

Registration Date

February 21, 2022

Previous Approval Numbers

国药准字H20193366

Drug Information

Generic Name

替格瑞洛片

Dosage Form

片剂

Strength

60mg

Drug Type

化学药品

Registration Date

February 21, 2022

Company Information

Applicant Company

Company Name扬子江药业集团广州海瑞药业有限公司

Company Address

广州高新技术产业开发区广州科学城香山路31号

Manufacturing Company

Company Name扬子江药业集团广州海瑞药业有限公司

Company Address

广州高新技术产业开发区广州科学城香山路31号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy